0001862143-23-000001.txt : 20230117 0001862143-23-000001.hdr.sgml : 20230117 20230117162537 ACCESSION NUMBER: 0001862143-23-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20230117 DATE AS OF CHANGE: 20230117 EFFECTIVENESS DATE: 20230117 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Slate Bio, Inc. CENTRAL INDEX KEY: 0001862143 IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-470922 FILM NUMBER: 23531823 BUSINESS ADDRESS: STREET 1: 310 2ND STREET SE, SUITE B CITY: CHARLOTTESVILLE STATE: VA ZIP: 22902 BUSINESS PHONE: 703-456-8000 MAIL ADDRESS: STREET 1: 310 2ND STREET SE, SUITE B CITY: CHARLOTTESVILLE STATE: VA ZIP: 22902 D 1 primary_doc.xml X0708 D LIVE 0001862143 Slate Bio, Inc. 310 2ND STREET SE, SUITE B CHARLOTTESVILLE VA VIRGINIA 22902 703-456-8000 DELAWARE None None Corporation true 2020 Andrew Krouse C/o Slate Bio, Inc. 310 2nd St SE, Suite B Charlottesville VA VIRGINIA 22902 Executive Officer Director Kyparissia Sirinakis C/o Slate Bio, Inc. 310 2nd St SE, Suite B Charlottesville VA VIRGINIA 22902 Director Robert Creeden C/o Slate Bio, Inc. 310 2nd St SE, Suite B Charlottesville VA VIRGINIA 22902 Director Brian Gallagher C/o Slate Bio, Inc. 310 2nd St SE, Suite B Charlottesville VA VIRGINIA 22902 Director Kurt Woerpel C/o Slate Bio, Inc. 310 2nd St SE, Suite B Charlottesville VA VIRGINIA 22902 Executive Officer Other Health Care Decline to Disclose 06b false 2022-12-30 false true false 0 2000008 1349960 650048 Sale of Series Seed-1 Preferred Stock. The company may sell up to an additional $650,048 worth of securities after the initial closing. false 6 0 0 0 false Slate Bio, Inc. /s/Andrew Krouse Andrew Krouse Chief Executive Officer 2023-01-17